| Safety Study of CZ10 in Healthy Volunteers (NCT06708767) | Nextrast, Inc. | 2050-01-01 |
| Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC (NCT06592664) | Lisata Therapeutics, Inc. | 2030-01-01 |
| Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care (NCT07456150) | VA Office of Research and Development | 2029-01-01 |
| Cannabichromene Safety in Rheumatoid Arthritis (NCT07087938) | Crystal Lederhos Smith | 2028-07-15 |
| Device for Bladder Control for Men With SCI (NCT07668063) | VA Office of Research and Development | 2028-06-01 |
| Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade Glioma (NCT07751744) | Jubilant Therapeutics Inc. | 2028-04-01 |
| A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy (NCT05896371) | CHU de Quebec-Universite Laval | 2028-03-01 |
| Prenatal Transplantation for Fetuses With Fanconi Anemia (NCT07408583) | Agnieszka Czechowicz | 2028-01-01 |
| Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML (NCT05662904) | German Cancer Research Center | 2028-01-01 |
| Psilocybin After Trauma Surgery for Pain (NCT07406828) | Trent Emerick | 2027-12-31 |
| BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion (NCT07594626) | Northwestern University | 2027-12-09 |
| A Phase 1 Open-Label, Dose-Ranging Safety and Pharmacokinetics Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML) (NCT07053020) | M.D. Anderson Cancer Center | 2027-12-01 |
| Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors (NCT07434609) | Nanolattix Biotechnology Co., Ltd. | 2027-12-01 |
| CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP) (NCT06752876) | Caribou Biosciences, Inc. | 2027-12-01 |
| Game Changers for Family Planning Peer Advocacy Program (NCT06048328) | RAND | 2027-11-15 |
| Terazosin for Dementia With Lewy Bodies (NCT04760860) | Qiang Zhang | 2027-10-01 |
| Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (NCT07594548) | Northwestern University | 2027-09-09 |
| Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury (NCT05217498) | Randy Trumbower, PT, PhD | 2027-09-01 |
| Anti-Interleukin-6 (IL6) in Calciphylaxis (NCT07708038) | Boston Medical Center | 2027-09-01 |
| A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers (NCT07176975) | Boehringer Ingelheim | 2027-08-03 |
| Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau (NCT06600880) | Columbia University | 2027-08-01 |
| Epidermal Growth Factor Receptor Inhibition for Keratinopathies (NCT06545695) | Northwestern University | 2027-07-01 |
| Behavioral Pharmacology of THC and Beta-Myrcene (NCT05432284) | Johns Hopkins University | 2027-07-01 |
| Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS) (NCT03653702) | Boston Children's Hospital | 2027-07-01 |
| Pilot Studies Testing the Use of Oral Amitriptyline in Reducing Localized Burn Injury-induced Microvesicle Particle Release (NCT07640061) | Wright State University | 2027-06-01 |
| The FORCE Trial Pilot: Fish Oil-enriched Nutrition for Radiotherapy in Cancer of the hEad and Neck (NCT07180576) | Anna Arthur, PhD | 2027-06-01 |
| ²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma (NCT04579523) | Fred Hutchinson Cancer Center | 2027-06-01 |
| Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab (NCT04266730) | UNC Lineberger Comprehensive Cancer Center | 2027-05-20 |
| Frequency-Dependent Effects of Transcranial Photobiomodulation on Cortical Excitability (NCT07707284) | Hospital de Clinicas de Porto Alegre | 2027-05-01 |
| Study of NM8074 in Adult C3 Glomerulopathy Patients (NCT05647811) | NovelMed Therapeutics | 2027-05-01 |
| Breakthrough - T1DM and Chronic Kidney Disease (NCT07592000) | University of Chicago | 2027-04-29 |
| Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma (NCT07758673) | City of Hope Medical Center | 2027-04-17 |
| Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment (NCT07463807) | National Cancer Institute (NCI) | 2027-04-12 |
| A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet (NCT07285967) | Hangzhou Yirui Pharmaceutical Technology Co., Ltd | 2027-04-01 |
| Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A (NCT03520751) | Nationwide Children's Hospital | 2027-04-01 |
| Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma (NCT07332507) | National Cancer Institute (NCI) | 2027-03-26 |
| Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso (NCT07730177) | Sanaria Inc. | 2027-03-01 |
| A Clinical Trial of Iron Supplementation for Youth With ADHD and Restless Sleep (NCT07061470) | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 2027-03-01 |
| Safety Study of XT-150 in Participants With ALS (NCT06704347) | Xalud Therapeutics, Inc. | 2027-03-01 |
| Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma (NCT07156227) | National Cancer Institute (NCI) | 2027-02-13 |
| Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications (NCT06649864) | Mayo Clinic | 2027-02-01 |
| Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias (NCT07765966) | RiboX Therapeutics Ltd. | 2027-02-01 |
| Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma (NCT06902012) | Zhujiang Hospital | 2027-02-01 |
| A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age (NCT07406347) | GlaxoSmithKline | 2027-01-25 |
| Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014) (NCT05093972) | Merck Sharp & Dohme LLC | 2027-01-22 |
| Study to Determine the Safety and Tolerability of TG-C in Subjects With Back Pain Due to Degenerative Disc Disease (NCT06144970) | Kolon TissueGene, Inc. | 2027-01-19 |
| Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30) (NCT07729397) | The Methodist Hospital Research Institute | 2027-01-15 |
| Decision Support Tool to Integrate PrEP Into Emergency Departments (NCT07279129) | George Washington University | 2027-01-15 |
| Preliminary Evaluation of the Safety and Tolerability of SPOT-mRNA01 Subcutaneously Administered in Healthy Subjects (NCT06567119) | SIPO Biotechnology Co. Ltd. | 2027-01-11 |
| ENCRT-103-hPI: Evaluation of an Immune-protected ENCRT-103-hPI Containing Primary Human Islets in Adults With Type 1 Diabetes, With and Without Standard-of-care Portal Vein Islet Infusion. (NCT07680673) | Encellin | 2027-01-06 |
| A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP). (NCT07729371) | Sapience Therapeutics | 2027-01-04 |
| Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma (NCT07691450) | City of Hope Medical Center | 2027-01-03 |
| Accelerated HEmodiafiltration in Severe Acute Diquat (AHEAD) Poisoning (NCT07234383) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2027-01-01 |
| Pilot and Feasibility Study of Anti-CD14 for the Treatment of Knee Osteoarthritis (NCT07481474) | VA Office of Research and Development | 2027-01-01 |
| Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life (2) (NCT07655141) | Hospital Universitario 12 de Octubre | 2027-01-01 |
| Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer. (NCT02802423) | BioLite, Inc. | 2027-01-01 |
| A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides (NCT07714187) | SecuraBio | 2027-01-01 |
| NG101m Adjuvant Therapy in Glioblastoma Patients (NCT04373785) | NeuGATE Theranostics | 2027-01-01 |
| Novel mRNA-LNP-Based Intratumoral Immunotherapy in Patients With Advanced Malignant Solid Tumors (NCT07587879) | IntraAb, Inc. | 2027-01-01 |
| Frequency-Dependent Effects of Transcranial Photobiomodulation With Same Peak Irradiance on Cortical Excitability and Fine Motor Performance (NCT07752602) | Hospital de Clinicas de Porto Alegre | 2027-01-01 |
| Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life (NCT07655128) | Hospital Universitario 12 de Octubre | 2027-01-01 |
| Intra-Arterial Bevacizumab as an Adjunct to Middle Meningeal Artery Embolization for Chronic Subdural Hematoma (NCT07729098) | Dheeraj Gandhi | 2027-01-01 |
| Relaxin Therapy for Atrial Fibrillation (NCT07359872) | Deeptankar DeMazumder | 2027-01-01 |
| Evaluation of the Safety and Efficacy of XoGlo Pro, a Placental Mesenchymal Stem Cell-derived Extracellular Vesicles in Treating COVID-19 Symptoms (NCT07664696) | Kimera Labs Inc. | 2027-01-01 |
| Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures (NCT03258658) | Wake Forest University Health Sciences | 2027-01-01 |
| CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM) (NCT04933422) | Crimson Biopharm Inc. | 2027-01-01 |
| Addressing Parental Tobacco Use in Somali Immigrant Families: Adapting an Evidence-Based Intervention in Primary Care (NCT06839729) | University of Minnesota | 2027-01-01 |
| Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI) (NCT05559801) | Emory University | 2027-01-01 |
| GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors (NCT07749976) | Vitruviae | 2027-01-01 |
| Evaluation of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU) (NCT07260162) | Institut Cancerologie de l'Ouest | 2027-01-01 |
| Ventricular mTOR Inhibition to Prevent Hydrocephalus After Brain Hemorrhage (NCT07662174) | Massachusetts General Hospital | 2027-01-01 |
| Sequential Immune Modulation and Antigen-Specific Tolerance Induction for Disease Modification in Recent-Onset Type 1 Diabetes (NCT07610213) | Abdullah Kars | 2027-01-01 |
| Safety and Immunogenicity Study of the DuoChol Oral Cholera Vaccine in Healthy Participants (NCT07270796) | International Vaccine Institute | 2027-01-01 |
| Magnetic Sentinel Lymph Node Mapping in Gastric Cancer (NCT05038098) | M.D. Anderson Cancer Center | 2026-12-31 |
| The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ONFH) (NCT03180463) | Sclnow Biotechnology Co., Ltd. | 2026-12-31 |
| Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa (NCT05539989) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2026-12-31 |
| Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period. (NCT03176498) | Sclnow Biotechnology Co., Ltd. | 2026-12-31 |
| Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases (NCT07523282) | Shenzhen MagicRNA Biotechnology Co., Ltd | 2026-12-31 |
| Study Of KITE-753 in R/R B-Cell ALL (NCT07674823) | M.D. Anderson Cancer Center | 2026-12-31 |
| SCLife®-UT hUC-MSCs Advanced Therapy Medicinal Products (hUC-MSCs ATMPs) for Patients With Thin Endometrial Infertility (NCT06503471) | Sclnow Biotechnology Co., Ltd. | 2026-12-31 |
| Phase 1 Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cell In Patients With Oral Premalignant Lesions (NCT07631013) | M.D. Anderson Cancer Center | 2026-12-31 |
| Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS) (NCT03184935) | Sclnow Biotechnology Co., Ltd. | 2026-12-31 |
| Venlafaxine Combined With Education and Behavioral Intervention for Bladder Pain Syndrome (NCT07698626) | Beijing Tiantan Hospital | 2026-12-31 |
| Efficacy and Safety of Pregabalin Combined With Educational and Behavioral Intervention for Bladder Pain Syndrome/Interstitial Cystitis (NCT07752134) | Beijing Tiantan Hospital | 2026-12-31 |
| A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants (NCT07341672) | Sunshine Lake Pharma Co., Ltd. | 2026-12-31 |
| The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction (NCT03186456) | Sclnow Biotechnology Co., Ltd. | 2026-12-31 |
| SCLife®-LDD hUC-MSCs Injection Therapy for Patients With Lumbar Intervertebral Disc Degeneration (NCT06589271) | Sclnow Biotechnology Co., Ltd. | 2026-12-31 |
| Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors (NCT06724042) | InSilico Medicine Hong Kong Limited | 2026-12-30 |
| Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy (NCT07628894) | City of Hope Medical Center | 2026-12-23 |
| Golcadomide in Combination With Rituximab for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT07578077) | City of Hope Medical Center | 2026-12-21 |
| Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (NCT07040982) | City of Hope Medical Center | 2026-12-19 |
| Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial (NCT07590583) | City of Hope Medical Center | 2026-12-19 |
| 64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic Cancer (NCT07608627) | City of Hope Medical Center | 2026-12-16 |
| Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss (NCT06437054) | Seoul National University Hospital | 2026-12-15 |
| Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy (NCT07354100) | University of Chicago | 2026-12-15 |
| BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation (NCT07583303) | City of Hope Medical Center | 2026-12-14 |
| Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension (NCT06770023) | Mayo Clinic | 2026-12-11 |
| Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients (NCT03686657) | ARKAY Therapeutics | 2026-12-10 |
| Safety and Efficacy of YB-1113 in Treatment of POI (NCT05494723) | Bright Cell, Inc. | 2026-12-09 |
| A Study of TIL in Advanced Solid Tumors (CZ) (NCT07294872) | Shanghai Juncell Therapeutics | 2026-12-08 |